hrp0089p3-p288 | Pituitary, Neuroendocrinology and Puberty P3 | ESPE2018

Bilateral Optic Nerve Hypoplasia Revealing Septo Optic Dysplasia or De Morsier Syndrome: A Case Report

Yamina Aribi , Meriem Bensaleh , Lila Brakni , Zoubir Sellal , Aicha Lachkhem , Samia Ouldkablia

Background: Septo-optic dysplasia (SOD) is a congenital affection characterized by classic triade: optic nerve hypoplasia, hypothalamic-pituitary endocrine deficits and mdline abnormalities of the brain. It is typically diagnosed in infancy and has a variable presentation.Case presentation: The patient is an 5 year old Algerian girl. At birth, bilateral congenital nystagmus and strabism was noted? Right blindness was suspected by parents at age of 2 year...

hrp0095p2-262 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | ESPE2022

Analyze of clinical, biological and therapeutic aspects of 46 XY DSD

Iabbassen Malek , Bensalah Meriem , Brahimi Hanane , Benabdellatif Katia , Sellal Zoubir , Zahaf Hamid , Mouloud Benaired Amine , Choutri Hichem , Khadidja Ouldkablia Samia

Background: Clinical spectrum of 46 XY DSD is characterized by a greatest diversity. Atypical sex development can occur through different steps of testicular differentiation. Etiologies of 46 XY DSD are termed gonadal dysgenesis, hormonal dysfunction and action. Its global incidence is unknown but the most common presentation, hypospadias, is understood to occur in 1 in 125 male births, and complete androgen insensitivity has an incidence of 1:20,000 people.</...

hrp0097p1-98 | GH and IGFs | ESPE2023

Evaluation of patients with growth hormone deficiency during the transition period

Bensalah Meriem , Iabbassen Malek , Haffaf Lounes , Bouchenna Amira , Lachkhem Aicha , Yahi Abdelkader , Sellal Zoubir , Medjaher Meriem , Khadidja Ouldkablia Samia

Introduction: The transition period between childhood and adulthood in patients with growth hormone deficiency is a vulnerable period during the follow-up. Different consensuses have established follow-up and reassessment protocols for this period in order to clarify whether GHD persists. The benefits of maintaining treatment during this period are widely documented on the metabolic, vascular, bone and in terms of quality of life and well-being.<p class="a...